🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04754854
Recruiting Observational

Reduction of Blood Recirculation in Veno-Venous ECMO

NCT04754854 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2020-11-20
Last updated
2024-12-31

Condition(s) studied

Extracorporeal Membrane OxygenationAcute Respiratory Distress Syndrome

Study summary

Blood which recirculates through the circuit of a veno-venous Extracorporeal Membrane Oxygenation (V-V ECMO) does not contribute to the systemic oxygenation of a patient on V-V ECMO and is called the recirculation fraction (Rf). Theoretically, the optimization of ECMO blood flow is possible using Rf measurements.

A prospective, observational study will be performed measuring the Rf of total ECMO blood flow in patients with acute respiratory distress syndrome (ARDS) on V-V ECMO with an ultrasound dilution technique.

ECMO blood flow will be optimized by reducing ECMO blood flow in accordance with the measured Rf as long as systemic oxygenation is not compromised.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Patients aged 18 years or older requiring veno-venous ECMO for treatment of refractory hypoxemia in ARDS.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin Germany Recruiting

More Charite University, Berlin, Germany trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04754854 on ClinicalTrials.gov ↗ ← All trials in Germany